Phase I trial of anti-CD3-stimulated CD4⁺ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer

Brendan D. Curti, Augusto C. Ochoa, Gerry C. Powers, William C. Kopp, W. Gregory Alvord, John E. Janik, Barry L. Gause, Barbara Dunn, Michael S. Kopreski, Robert Fenton, Arnold Zea, Claudio Dansky-Ullmann, Susan Strobl, Linda Harvey, Edward Nelson, Mario Sznol, Dan L. Longo

Research output: Contribution to journal › Article › peer-review